3don MSN
Another GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it’s used
The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...
You can track the start of spring and the phases of the moon—or you can turn to a formula by mathematician Carl Friedrich ...
OpenAI is shutting down Sora, its controversial and disruptive text-to-video generative AI model. The end of Sora also ends ...
As droughts worsen and freshwater grows scarce, desalination is expanding rapidly. More than 20,000 plants now convert ...
Rep. Seth Moulton (D-Mass.) ripped Polymarket on Friday after the popular prediction market platform allowed users to place ...
Orforglipron is the second daily weight-loss pill to hit the market. The first was the Wegovy pill, from Novo Nordisk, which ...
A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.
Tech Xplore on MSN
Fair decisions, clear reasons: Creating fuzzy AI with fairness built in from the start
Although AI is not intentionally biased, it can inherit biases from the data fed into it, learning and repeating them until ...
People on Foundayo, the new GLP-1 weight loss pill from Eli Lilly, tend to feel full faster, and may experience nausea, ...
The daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form ...
The Easter celebration has arrived in Fisch for 2026, and, as usual, there is an exclusive Egg hunt. This time around, there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results